North Shore University Hospital is a part of Northwell Health, New York State's largest healthcare provider and private employer.

There are 738 beds in North Shore University Hospital.

During the past decade, North Shore University Hospital conducted 203 clinical trials. In the 10-year time frame, 203 clinical trials started and 181 clinical trials were completed, i.e. on average, 89.2% percent of trials that started reached the finish line to date. In the past 5 years, 95 clinical trials started and 80 clinical trials were completed. i.e. 84.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Shore University Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 85 trials, followed by "National Cancer Institute (NCI)" with 58 trials sponsored, "Radiation Therapy Oncology Group" with 50 trials sponsored, "Northwell Health" with 49 trials sponsored and "Gynecologic Oncology Group" with 49 trials sponsored. Other sponsors include 396 different institutions and companies that sponsored additional 194 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Shore University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 239 trials as a collaborator, "Cancer and Leukemia Group B" with 26 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator, "SWOG Cancer Research Network" with 21 trials as a collaborator and "Eastern Cooperative Oncology Group" with 13 trials as a collaborator. Other collaborators include 390 different institutions and companies that were collaborators in the rest 237 trials.

According to Clinical.Site data, the most researched conditions in "North Shore University Hospital" are "HIV Infections" (36 trials), "Leukemia" (32 trials), "Lung Cancer" (26 trials), "Lymphoma" (26 trials) and "Breast Cancer" (25 trials). Many other conditions were trialed in "North Shore University Hospital" in a lesser frequency.

Most popular intervention types in "North Shore University Hospital" are "Drug" (426 trials), "Other" (119 trials), "Biological" (106 trials), "Procedure" (96 trials) and "Device" (93 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (51 trials), "Laboratory Biomarker Analysis" (45 trials), "Placebo" (41 trials), "paclitaxel" (27 trials) and "cisplatin" (26 trials). Other intervention names were less common.

The vast majority of trials in "North Shore University Hospital" are 562 trials for "All" genders, 91 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are 144 active trials in "North Shore University Hospital". 1 are not yet recruiting, 64 are recruiting, 74 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 429 completed trials in North Shore University Hospital, 5 suspended trials, and 66 terminated clinical trials to date.

Out of the total trials that were conducted in North Shore University Hospital, 44 "Phase 1" clinical trials were conducted, 212 "Phase 2" clinical trials and 223 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 115 trials that are defined as “Not Applicable".